Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Automated Microbial Diagnostics

Automated Microbial Diagnostics

Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Inequalities in childhood pneumococcal conjugate vaccine uptake in England before and after the change from a 2 + 1 to 1 + 1 schedule: a longitudinal study.

The Lancet regional health. Europe·2026

Same author

Child poverty and declining measles, mumps and rubella (MMR) vaccination in England, 2015 to 2024. A longitudinal ecological study at local area level.

medRxiv : the preprint server for health sciences·2026

Same author

Genomic and statistical models to characterize <i>Streptococcus pneumoniae</i> transmission patterns in Malawi.

Microbial genomics·2026

Same author

Procalcitonin testing combined with NEWS2 evaluation compared with usual care based on NEWS2 for identification of sepsis and antibiotic initiation in the emergency department in England and Wales (PRONTO): a multicentre, randomised, controlled, open-label, phase 3 trial.

The Lancet. Respiratory medicine·2026

Same author

Burden of <i>Shigella</i> and enterotoxigenic <i>Escherichia coli</i> infections among children under 5 years in Ethiopia, Kenya and Malawi: a systematic review and meta-analysis.

BMJ global health·2026

Same author

Serotype-specific pneumococcal invasiveness: a global meta-analysis of paired estimates of disease incidence and carriage prevalence.

The Lancet. Microbe·2026

Search research articles

Related Experiment Video

Updated: Jun 14, 2026

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

Biomarkers - SMi's Third Summit: discovery, validation & qualification.

¹University of Liverpool, MRC Centre for Drug Safety Science, Sherrington Buildings, Liverpool, UK. neil.french@liv.ac.uk

Idrugs : the Investigational Drugs Journal

|April 8, 2010

Summary

This conference report summarizes advancements in biomarker development, covering new technologies, therapeutic applications, and safety considerations for cancer and other diseases. Key insights into novel biomarkers were presented.

More Related Videos

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

Related Experiment Videos

Last Updated: Jun 14, 2026

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

Area of Science:

Biomarker discovery and development
Translational research in oncology and disease diagnostics
Biomarker safety and regulatory science

Background:

The Third Summit on Biomarkers convened experts to discuss emerging trends and challenges in the field.
Focus areas included technological innovations and therapeutic applications of biomarkers.
The summit addressed the critical need for novel biomarkers in disease detection and management.

Framework:

Presentations highlighted innovative methodologies for biomarker identification and validation.
Discussions explored the integration of multi-omics data for enhanced biomarker signatures.
Case studies demonstrated the translation of research findings into clinical applications.

Implementation:

Novel biomarkers for various cancers and other complex diseases were showcased.
Technological advancements in high-throughput screening and data analysis were detailed.
Strategies for addressing safety and ethical considerations in biomarker research were deliberated.

Implications:

Advancements presented promise improved diagnostic accuracy and personalized treatment strategies.
The development of novel biomarkers can accelerate drug discovery and clinical trial design.
Enhanced understanding of biomarker safety is crucial for clinical adoption and patient well-being.